BioCentury
ARTICLE | Financial News

Jazz Pharmaceuticals financial update

May 13, 2013 7:00 AM UTC

Jazz said its board authorized the repurchase of up to $200 million of the company's stock. The company, which closed Friday at $57.96, has 58.9 million shares outstanding. ...